13F HOLDINGS REPORT
Propel Bio Management, LLC
Quarter ended Q3 2024 · Filed November 13, 2024 · Accession 0001829126-24-007453
Total Value
$172.4M
Positions
21
Other Managers
1
Confidential Omitted
No
Holdings (21)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APPLIED THERAPEUTICS INC | 03828A101 | 6,567,858 | $55.8M | 32.38% |
| 2 | PLAINS GP HOLDINGS LP-CL | PAGP | 1,272,360 | $23.5M | 13.65% |
| 3 | PHATHOM PHARMACEUTICALS I | PHAT | 869,927 | $15.7M | 9.12% |
| 4 | ACHIEVE LIFE SCIENCES INC | ACHV | 2,453,092 | $11.6M | 6.74% |
| 5 | TSCAN THERAPEUTICS INC | TCRX | 2,087,139 | $10.4M | 6.03% |
| 6 | AKERO THERAPEUTICS INC | 00973Y108 | 343,729 | $9.9M | 5.72% |
| 7 | MADRIGAL PHARMACEUTICALS | MDGL | 43,032 | $9.1M | 5.30% |
| 8 | AVIDITY BIOSCIENCES INC | 05370A108 | 178,500 | $8.2M | 4.76% |
| 9 | ARDELYX INC | ARDX | 1,070,947 | $7.4M | 4.28% |
| 10 | TELESAT CORP | TSAT | 365,781 | $4.8M | 2.79% |
| 11 | ABEONA THERAPEUTICS INC | ABEO | 624,022 | $3.9M | 2.29% |
| 12 | KYMERA THERAPEUTICS INC | KYMR | 56,359 | $2.7M | 1.55% |
| 13 | SYNDAX PHARMACEUTICALS IN | SNDX | 133,259 | $2.6M | 1.49% |
| 14 | KURA ONCOLOGY INC | KURA | 130,000 | $2.5M | 1.47% |
| 15 | ZEVRA THERAPEUTICS INC | ZVRA | 179,874 | $1.2M | 0.72% |
| 16 | EIGER BIOPHARMACEUTICALS | 28249U204 | 146,381 | $1.2M | 0.72% |
| 17 | ATHIRA PHARMA INC | 04746L104 | 1,492,792 | $665,785 | 0.39% |
| 18 | COMPASS PATHWAYS LTD | CMPS | 80,000 | $504,000 | 0.29% |
| 19 | VERRICA PHARMACEUTICALS I | VRCA | 344,937 | $500,159 | 0.29% |
| 20 | MAAT PHARMA SACA | F5888J116 | 2,397 | $17,786 | 0.01% |
| 21 | CHINOOK THERAPEUTICS | 169CVR016 | 79,357 | $9,750 | 0.01% |